Skip to main content
Log in

Trial watch

Opportunities and challenges of the 2016 target landscape

  • Biobusiness Briefs
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Examination of the target landscape in 2016.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyle Lafferty-Whyte.

Ethics declarations

Competing interests

All authors are full-time employees of Clarivate Analytics, which produces and sells the content and related products used to produce this analysis.

Supplementary information

Supplementary information S1 (box)

Data and analysis (PDF 111 kb)

Supplementary information

Supplementary information S2 (table) (XLSX 60 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lafferty-Whyte, K., Mormeneo, D. & del Fresno Marimon, M. Opportunities and challenges of the 2016 target landscape. Nat Rev Drug Discov 16, 10–11 (2017). https://doi.org/10.1038/nrd.2016.263

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2016.263

  • Springer Nature Limited

This article is cited by

Navigation